Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Susan McCune, MD (she/her/hers)

Vice President, Pediatrics & Clinical Pharmacology
PPD, Part of Thermo Fisher Scientific

Dr. Susan McCune joined PPD in 2021 from the Food and Drug Administration (FDA) where she was the Director in the Office of Pediatric Therapeutics (OPT) in the Office of the Commissioner. She joined the FDA in 2003 in the Division of Pediatric Drug Development, Office of Counter-Terrorism and Pediatric Drug Development, in the Center for Drug Development and Research (CDER). From 2005 through 2009, Dr. McCune held the positions of Associate Director and team leader in the Office of Counter-Terrorism and Emergency Coordination in CDER. She joined the Office of Translational Sciences in CDER in February, 2010 as the Deputy Director, staying in that position until January, 2017. In addition to the Deputy role, she was the lead for the Translational Medicine Team, the co-director of the Biomarker Qualification Program, and the scientific lead for the Critical Path Innovation Meetings program. In 2015, Dr. McCune worked with the Critical Path Institute to launch the International Neonatal Consortium (INC). Prior to joining the FDA, Dr. McCune was an Associate Professor in the Department of Neonatology at Children’s National Medical Center.


Dr. McCune received her medical degree from George Washington University following her undergraduate degree at Harvard University. She completed her internship, residency, chief residency, and neonatal fellowship at Children’s National Medical Center in Washington, D.C. She is Board Certified in Pediatrics and Neonatal/Perinatal Medicine. For 15 years, while practicing academic pediatric and neonatal medicine at Johns Hopkins and Children's National Medical Center, Dr. McCune continued her molecular biology research on adrenergic receptor ontogeny and expression in models of newborn brain injury in the Lab of Developmental Neurobiology, NICHD, NIH. In addition, she has a Masters in Education Technology Leadership from George Washington University, and certificates in Public Health from Georgetown and Regulatory Science from USC.

Disclosure information not submitted.

Presentation(s):